Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 28, 1998 - Issue 5
23
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Rat CYP24 catalyses 23S-hydroxylation of 26,26,26,27,27,27-hexafluorocalcitriol in vitro

, , &
Pages 457-463 | Published online: 22 Sep 2008

References

  • AKIYOSHI -SHIBATA, M., SAKAKI, T., OHYAMA, Y., NOSHIRO, M., OKUDA, K. and YABUSAKI, Y., 1994, Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase: a study with the mature enzyme expressed in Escherkhia coli. European Journal of Biochemistry, 224, 335–343.
  • BARNES, H. J., ARLOTTO, M. P. and WATERMAN, M. R., 1991, Expression and enzymatic activity of recombinant cytochrome P450 17a-hydroxylase in Escherichia coli. Proceedings of the National Academy of Sciences, USA, 88, 5597–5601.
  • BECKMAN, M. J., TADIKONDA, P., WERNER, E., PRAHL, J., YAMADA, S. and DELucA, H. F., 1996, Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme. Biochemistry, 35, 8465–8472.
  • DARWISH, H. and DELucA, H. F., 1993, Vitamin D-regulated gene expression. Critical Reviews in Eukaryotic Gene Expression, 3, 89–116.
  • HARADA, M., MIYAHARA, T., KAJITA -KONDO, S., KOZAKAI, A., HIGUCHI, S., OTOMO, S. and KOZUKA, H., 1994, Differences in metabolism between 26,26,26,27, 27,27-hexafluoro-1a,25-dihydroxyvitamin D3 and 1a,25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria. Research Communications in Molecular Pathology and Pharmacology, 86, 183–193.
  • HONDA, A., NAKASHIMA, N., MORI, Y., KATSUMATA, T. and IsmzuKA, S., 1992, Effects of vitamin D - binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxyvitamin D3. Journal of Steroid Biochemistry and Molecular Biology, 41, 109–112.
  • HOND A., NAKASHIMA N., SHIDA, Y., NAGATA, A. and IsHizuKA, S., 1993, Modification of 1a,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27 -hexafluoro-1 a,23 (S),25 -trihydroxyvitamin D3. Biochemical Journal, 295, 509–516.
  • INABA, M., OKUNO, S., NISHIZAWA, Y., YUKIOKA, K., OTANI, S., MATSUI -YUASA, I., MORISAWA, S., DELUCA, H. F. and MORII, H., 1987, Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60. Archives in Biochemistry and Biophysics, 258, 421–425.
  • INABA, M., OKUNO, S., NISHIZAWA, Y., IMANISHI, Y., KATSUMATA, T., SUGATA, I. and MORE, H., 1993, Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3. Biochemistry and Pharmacology, 45, 2331–2336.
  • KIRIYAMA, Y., OKAMOTO, S., EJIMA, E., KURIHARA, N., HAICEDA, Y., ITo, N., I zumi, M., KUMEGAWA, M. and NAGATAKI, S., 1991, Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells. Endocrinology, 128, 81–86.
  • LOHNES, D. and JoNEs, G., 1987, Side chain metabolism of vitamin D3 in osteosarcoma cell line UMP-106 : characterization of products. Journal of Biological Chemistry, 262, 14394–14401.
  • NAGATA, A., HAMMA, N., KATSUMATA, T., SATO, R., KOMURO, S., IBA, K., YOSHITAKE, A., KIRIYAMA, T., OKAMOTO, S., NAGATAKI, S. and MORII, H., 1988, Mechanism of action of 26,27-hexafluoro-1,25(OH)2D3. In Vitamin D: Molecular, Cellular and Clinical Endocrinology, edited by A. W. Norman, K. Schaefer, H.-G. Grigoleit and D. V. Herrath (Berlin: Walter de Gruyter), pp. 141–142.
  • NONAKA, Y., AIBARA, S., SUGIYAMA, T., YAMANO, T. and MORITA, Y., 1985, A crystallographic investigation on NADPH-adrenodoxin oxidoreductase. Journal of Biochemistry (Tokyo), 98, 257–260.
  • REDDY, G. S., TSERNG, K. Y., THOMAS, B. R., DAYAL, R. and NORMAN, A. W., 1987, Isolation and identification of 1,23-dihydroxy-24,25,26,27-tetranorvitamin D3, a new metabolite of 1,25 - dihydroxyvitamin D3 produced in rat kidney. Biochemistry, 26, 324–331.
  • SAKAKE T., AKIYOSHI -SHIBATA, M., YABUSAKI, Y., MANABE, K., MURAKAMI, H. and OHKAWA, H., 1991, Progesterone metabolism in recombinant yeast simultaneously expressing bovine cytochromes P450c17 (CYP17A1) and P450c21 (CYP21B1) and yeast NADPH-P450 oxidoreductase. Pharmacogenetks, 1, 86–93.
  • SASAKI, H., HARADA, H., HANDA, Y., MORINO, H., SUZAWA, M., SHIMPO, E., KATSUMATA, T., MASUHIRO Y., MATSUDA, K., EBIHARA, K., ONO, T., MASUSHIGE, S. and KATO, S., 1995, Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Biochemistry, 34, 370–377.
  • TANAKA, Y., DELucA, H. F., KOBAYASHI, Y. and IKEKAwA, N., 1984, 26,26,26,27,27,27-Hexafluoro-1,25-dihydroxyvitamin D3: a highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3. Archives of Biochemistry and Biophysics, 229, 348–354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.